. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBone Density Conservation Agents/adverse effectsBone Density Conservation Agents/therapeutic useCalcitonin/adverse effectsCalcitonin/therapeutic useCalcium/therapeutic useDenosumabDiphosphonates/adverse effectsDiphosphonates/therapeutic useDrug CombinationsEstrogens/adverse effectsEstrogens/therapeutic useFemaleHumansNonprescription Drugs/adverse effectsNonprescription Drugs/therapeutic useOsteoporosis, Postmenopausal/drug therapyOsteoporosis, Postmenopausal/physiopathologyParathyroid Hormone/adverse effectsParathyroid Hormone/therapeutic usePractice Guidelines as TopicPrescription Drugs/adverse effectsPrescription Drugs/therapeutic useRANK Ligand/adverse effectsRANK Ligand/therapeutic useRandomized Controlled Trials as TopicVitamin D/therapeutic use
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedBone Density Conservation AgentsDiphosphonatesDrug CombinationsEstrogensNonprescription DrugsParathyroid HormonePrescription DrugsRANK LigandVitamin DDenosumabCalcitoninCalcium
Year: 2008 PMID: 18800025
Source DB: PubMed Journal: Treat Guidel Med Lett ISSN: 1541-2784